Home > Press > NanoMed, Inc. Spins Out of Zyvex Labs
Zyvex Labs today announced its first company spinout: NanoMed, Inc. The new company was started by Rob Burgess, PhD, former Vice President of Research & Development at Zyvex Instruments, and Gareth Hughes, PhD, former Group Leader of Life Sciences at Zyvex Corporation.
NanoMed, Inc. Spins Out of Zyvex Labs
RICHARDSON, TX | Posted on August 22nd, 2007
NanoMed is focused on the application of nanotechnology in Life Sciences. The company seeks to apply nanoparticle technologies for the development of research grade reagents and cutting-edge therapeutics. In addition, NanoMed possesses a strong collection of nanotechnology platforms that are currently available for licensing. The new company leverages Zyvex's existing Life Science patents, proprietary methods, and core technologies.
"We are delighted to obtain assignment of the nanoparticle dispersion intellectual property from Zyvex Labs," said Rob Burgess, Ph.D., NanoMed's Co-Founder and Chairman of the Board. "The application of Zyvex Performance Materials' Kentera(TM) and other polymers for functionalizing carbon nanotubes will play an integral role in solidifying NanoMed's portfolio of cutting-edge nanotechnologies as they relate to the biomedical sciences. We look forward to continuing a productive partnership with Zyvex Labs and Zyvex Performance Materials."
"Rob is a focused leader with outstanding technology development skills," said Zyvex Founder Jim Von Ehr. "He also has a proven track record in growing businesses. I expect to see exciting new products from this new venture."
NanoMed's focus centers around the functionalization and specific delivery of nanoparticles for applications in various biomedical markets, including the research, diagnostics, therapeutics, and veterinary sectors. In collaboration with their strategic partners, NanoMed researchers have developed promising technologies that will allow for the effective use of nanotechnology-based solutions to address a variety of issues across multiple scientific disciplines, including basic biomedical research and applied science related to disorders such as cancer and infectious diseases.
Other founders include Rocky Draper, PhD, Professor at the University of Texas at Dallas, and Ellen Vitetta, PhD, Professor and Director of the Cancer Immunobiology Center at the University of Texas Southwestern Medical Center in Dallas.
More information about NanoMed's technologies and business strategy can be found at http://www.nanomedinc.com/ .
For more information, please click here
P.O. Box 850922
Richardson, Texas 75085-0922
Copyright © PR Newswire Association LLC.
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
NYU Researchers Break Nano Barrier to Engineer the First Protein Microfiber October 23rd, 2014
Iranian Scientists Apply Nanotechnology to Produce Surgery Suture October 23rd, 2014
RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014
Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014
Nanoparticle technology triples the production of biogas October 23rd, 2014
SUNY Polytechnic Institute Invites the Public to Attend its Popular Statewide 'NANOvember' Series of Outreach and Educational Events October 23rd, 2014
Advancing thin film research with nanostructured AZO: Innovnano’s unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014
Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014
PEN Inc. Chairman, Scott Rickert, Will Webcast a Live Company Update September 25, 1 PM EDT September 17th, 2014
State University of New York Trustees Unanimously Approve SUNY Polytechnic Institute (SUNY Poly) as New Name for Merged SUNY CNSE / SUNYIT September 9th, 2014
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Applied Nanotech Holdings, Inc. and NanoHoldings Inc. Complete Combination to Create PEN Inc.: New Company to Focus on Commercialization of Advanced Nanotechnology-Enabled Products; Scott Rickert Is Chairman and CEO September 2nd, 2014